VQB Wins $1 Million to Commercialize System for Early Detection of DPN

VisionQuest Biomedical founder and CEO Peter Soliz (PhD) has just been awarded a $1 million Commercialization Readiness Pilot Program (CRP) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (part of the US National Institutes of Health) for his work on early detection of DPN. With the support of this grant, Dr. Soliz will develop a commercial prototype and seek FDA approval of i-RxTherm, his device for detecting DPN (diabetic peripheral neuropathy or diabetic foot).